Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Laxido Orange oral powder sachets sugar free
0106040M0BCACAA
|
Laxido | Macrogol 3350 | Gastro-Intestinal System | 302,779 |
|
Laxido Paediatric Plain oral powder 6.9g sachets
0106040M0BCADAB
|
Laxido | Macrogol 3350 | Gastro-Intestinal System | 71,831 |
|
Laxido Orange oral powder sachets
0106040M0BCAAAE
|
Laxido | Macrogol 3350 | Gastro-Intestinal System | 59 |
|
Laxido Natural oral powder 13.7g sachets
0106040M0BCABAA
|
Laxido | Macrogol 3350 | Gastro-Intestinal System | 4 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.